Similar articles

• [Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide)].

  Loubatières A, Ribes G, Mariani MM, Alric R. Loubatières A, et al. Acta Diabetol Lat. 1973 Mar-Apr;10(2):261-82. Acta Diabetol Lat. 1973. PMID: 4200420 Italian. No abstract available.
• Uptake of glibornuride by microdissected pancreatic islets.

  Täljedal IB. Täljedal IB. Horm Res. 1974;5(4):211-6. doi: 10.1159/000178633. Horm Res. 1974. PMID: 4210148 No abstract available.
• [Extrapancreatic effects of sulfonylurea compounds. 3. Studies on the additional blood sugar decreasing and antilipolytic effect of tolbutamide, glibornuride, and glibenclamide on completely pancreatectomized dogs, chronically treated with insulin during acute experiment and following pretreatment with sulfonylurea compounds using small doses of sulfonylurea].

  Beyer J, Cordes U, Sell G, Schöffling K. Beyer J, et al. Arzneimittelforschung. 1972 Dec;22:Suppl 12A:2176. Arzneimittelforschung. 1972. PMID: 4198965 German. No abstract available.
• [Current concepts of the pancreatic and extrapancreatic mechanisms of the action of peroral hypoglycemic sulfonylurea preparations].

  Poltorak VV, Gladkikh AI. Poltorak VV, et al. Probl Endokrinol (Mosk). 1985 Mar-Apr;31(2):76-85. Probl Endokrinol (Mosk). 1985. PMID: 2859589 Review. Russian. No abstract available.
• Glibenclamide, a new sulphonylurea: whither oral hypoglycaemic agents?

  Marble A. Marble A. Drugs. 1971;1(2):109-15. doi: 10.2165/00003495-197101020-00001. Drugs. 1971. PMID: 4999930 Review. No abstract available.